Virbac SA
Closed
SectorHealthcare
339 1.65
Overview
Share price change
24h
Min
328.5
Max
339.5
Income | -14M 68M |
|---|---|
Sales | -12M 726M |
P/E Sector Avg | 18.906 50.958 |
Dividend yield | 0.44 |
Profit margin | 9.427 |
Employees | 6,442 |
EBITDA | -35M 121M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +22.78% upside |
Dividend yield Sector Avg | 0.44% 2.41% |
|---|---|
Next Earnings | 17 Sept 2026 |
Market Cap | 52M 2.9B |
|---|---|
Previous open | 337.35 |
Previous close | 339 |
News Sentiment
By Acuity
24%
76%
54 / 342 Healthcare
Virbac SA Chart
Past performance is not a reliable indicator of future results.
About Virbac SA
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
